TSC22 Domain Family Member 3 Links Natural Killer Cells to CD8⁺T Cell-Mediated Drug Hypersensitivity

Scientists highlighted the importance of natural killer cell heterogeneity and TSC22D3 in immune-mediated hypersensitivity disorders, offering potential therapeutic targets for severe cutaneous adverse drug reactions and related conditions.